Convalescent plasma as a potential therapy for COVID-19

Long Chen; Jing Xiong; Lei Bao; Yuan Shi

doi:10.1016/s1473-3099(20)30141-9

Keywords

MedicineConvalescent plasmaExtracorporeal membrane oxygenationCoronavirusMethylprednisolonePneumoniaCoronavirus disease 2019 (COVID-19)OutbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DiseaseSevere acute respiratory syndromeMortality rateIntensive care medicineInternal medicineVirologyInfectious disease (medical specialty)

Affiliated Institutions

Related Publications

Functional exhaustion of antiviral lymphocytes in COVID-19 patients

Meijuan Zheng , Yong Gao , Gang Wang +5 more

In December 2019, a novel coronavirus was first reported in Wuhan, China. It was named by the World Health Organization as severe acute respiratory syndrome coronavirus 2 (SARS-...

2020 Cellular and Molecular Immunology 1841 citations

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Takuya Sekine , André Perez‐Potti , Olga Rivera‐Ballesteros +75 more

SARS-CoV-2-specific memory T cells will likely prove critical for long-term immune protection against COVID-19. Here, we systematically mapped the functional and phenotypic...

2020 Cell 1940 citations

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

Masaki Imai , Kiyoko Iwatsuki‐Horimoto , Masato Hatta +31 more

Significance Since SARS-CoV-2 emerged in China, it has spread rapidly around the world. Effective vaccines and therapeutics for SARS-CoV-2−induced disease (coronavirus disease 2...

2020 Proceedings of the National Academy o... 1134 citations

A serological assay to detect SARS-CoV-2 seroconversion in humans

Fatima Amanat , Daniel Stadlbauer , Shirin Strohmeier +27 more

Here, we describe a serological enzyme-linked immunosorbent assay for the screening and identification of human SARS-CoV-2 seroconverters. This assay does not require the handli...

2020 Nature Medicine 1934 citations

Clinical and immunological features of severe and moderate coronavirus disease 2019

Guang Chen , Di Wu , Wei Guo +17 more

BACKGROUNDSince December 2019, an outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, and is...

2020 Journal of Clinical Investigation 4983 citations

Publication Info

Year: 2020
Type: letter
Volume: 20
Issue: 4
Pages: 398-400
Citations: 1083
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Convalescent plasma as a potential therapy for COVID-19

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1083

OpenAlex

Cite This

APA Style

                            
                                
                                    Long Chen, 
                                
                                    Jing Xiong, 
                                
                                    Lei Bao
                                
                                et al.
                            
                            (2020). 
                            Convalescent plasma as a potential therapy for COVID-19. 
                            The Lancet Infectious Diseases
                            , 20
                            (4)
                            , 398-400.
                            https://doi.org/10.1016/s1473-3099(20)30141-9
                        

Identifiers

DOI: 10.1016/s1473-3099(20)30141-9